Global Pruritus Therapeutic Market 2017-2021

掻痒症治療薬の世界市場2017-2021

◆タイトル:Global Pruritus Therapeutic Market 2017-2021
◆商品コード:IRTNTR13976
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年8月2日
◆ページ数:81
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、掻痒症治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、掻痒症治療薬の世界市場規模及び予測、投与経路(ROA)別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社は掻痒症治療薬の世界市場が2017-2021年期間中に年平均4.95%成長すると予測しています。当レポート上に記載されている主な企業は• Allergan• GlaxoSmithKline• Pfizer• Sanofi等です。

・エグゼクティブサマリー
・掻痒症治療薬の世界市場:市場概観
・掻痒症治療薬の世界市場:市場規模及び予測
・掻痒症治療薬の世界市場:投与経路(ROA)別分析
・掻痒症治療薬の世界市場:地域別分析
・掻痒症治療薬の世界市場:アジア市場規模
・掻痒症治療薬の世界市場:アメリカ市場規模
・掻痒症治療薬の世界市場:ヨーロッパ市場規模
・掻痒症治療薬の世界市場:成長要因
・掻痒症治療薬の世界市場:課題
・掻痒症治療薬の世界市場:市場動向
・掻痒症治療薬の世界市場:競争状況
・掻痒症治療薬の世界市場:主要企業(ベンダー)分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About Global Pruritus Therapeutic
Pruritus is defined as the unpleasant skin sensation that frequently provokes scratching. Various systemic diseases are the major cause of pruritus. The intensity of sensation ranges from mild to severe. Various diseases cause changes/imbalance of biochemical factors, which trigger skin sensation and lead to pruritus. The market is segmented based on these disease conditions, which are responsible for pruritus.

Technavio’s analysts forecast the global pruritus therapeutic market to grow at a CAGR of 4.95% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global pruritus therapeutic market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Pruritus Therapeutic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Allergan
• GlaxoSmithKline
• Pfizer
• Sanofi

[Other prominent vendors]
• Abbott
• Ajanta Pharma
• Almirall
• Astellas Pharma
• Bristol-Myers Squibb
• CARA Therapeutic
• Cipla
• Eisai
• Eli Lilly
• Galderma
• Glenmark
• Heron Therapeutic
• IPCA
• Lupin
• Merck
• Novartis
• Sun Pharma
• Takeda Pharmaceutical

[Market driver]
• Drug-induced pruritus
• For a full, detailed list, view our report

[Market challenge]
• Poor patient adherence due to inadequate information on drug usage
• For a full, detailed list, view our report

[Market trend]
• Incorporation of novel technology for product development
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market overview
• Five forces analysis

PART 06: Pipeline landscape

PART 07: Market segmentation by disease type
• Renal pruritus
• Cholestatic pruritus
• Hematologic pruritus
• Endocrine pruritus
• Oncological pruritus

PART 08: Market segmentation by route of administration (ROA)

PART 09: Geographical segmentation
• Pruritus therapeutic market in Americas
• Pruritus therapeutic market in EMEA
• Pruritus therapeutic market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Market challenges

PART 12: Market trends
• Identification of new T-cell subsets (Th17 and Th22)
• Incorporation of novel technology for product development
• Inorganic growth strategies

PART 13: Vendor landscape
• Competitive scenario

PART 14: Key vendor analysis
• Allergan
• GlaxoSmithKline
• Pfizer
• Sanofi
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits] 
Exhibit 01: Types of pruritus based on causative disease
Exhibit 02: Chemical substances that trigger pruritus
Exhibit 03: Major diseases that cause pruritus
Exhibit 04: Major drug classes that induce pruritus
Exhibit 05: Global pruritus therapeutic market drivers
Exhibit 06: Global pruritus therapeutic market 2016-2021 ($ millions)
Exhibit 07: Opportunity analysis in global pruritus therapeutic market
Exhibit 08: Five forces analysis
Exhibit 09: Pipeline molecules based on vendors
Exhibit 10: Key clinical trials
Exhibit 11: Segmentation of global pruritus therapeutic market by disease type 2016
Exhibit 12: Segmentation of global pruritus therapeutic market share by disease type 2016
Exhibit 13: Global renal pruritus therapeutic market 2016-2021 ($ millions)
Exhibit 14: Global cholestatic pruritus therapeutic market 2016-2021 ($ millions)
Exhibit 15: Global hematologic pruritus therapeutic market 2016-2021 ($ millions)
Exhibit 16: Global endocrine pruritus therapeutic market 2016-2021 ($ millions)
Exhibit 17: Global oncological pruritus therapeutic market 2016-2021 ($ millions)
Exhibit 18: Various ROAs applied for pruritic drugs 2016
Exhibit 19: Segmentation of global pruritus therapeutic market by geography 2016 and 2021
Exhibit 20: Global pruritus therapeutic market revenue by geography 2016-2021 ($ millions)
Exhibit 21: Market scenario in Americas
Exhibit 22: Pruritus therapeutic market in Americas 2016-2021 ($ millions)
Exhibit 23: Market scenario in EMEA
Exhibit 24: Pruritus therapeutic market in EMEA 2016-2021 ($ millions)
Exhibit 25: Market scenario in APAC
Exhibit 26: Pruritus therapeutic market in APAC 2016-2021 ($ millions)
Exhibit 27: Prevalence of pruritus in various disease conditions
Exhibit 28: Various drugs responsible for inducing pruritus
Exhibit 29: Phase III drugs for management of pruritus
Exhibit 30: Global sales of Allegra 2008 and 2016 ($ millions)
Exhibit 31: Role of newer T-cell subsets in dermatological diseases
Exhibit 32: Inorganic growth strategies
Exhibit 33: Competitive structure analysis of global pruritus therapeutic market 2016
Exhibit 34: Market penetration of various global pruritus therapeutic manufacturers 2016
Exhibit 35: Strategic success factors of companies in global pruritus therapeutic market
Exhibit 36: Allergan: Key highlights
Exhibit 37: Allergan: Strength assessment
Exhibit 38: Allergan: Strategy assessment
Exhibit 39: Allergan: Opportunity assessment
Exhibit 40: GlaxoSmithKline: Key highlights
Exhibit 41: GlaxoSmithKline: Strength assessment
Exhibit 42: GlaxoSmithKline: Strategy assessment
Exhibit 43: GlaxoSmithKline: Opportunity assessment
Exhibit 44: Pfizer: Key highlights
Exhibit 45: Pfizer: Strength assessment
Exhibit 46: Pfizer: Strategy assessment
Exhibit 47: Pfizer: Opportunity assessment
Exhibit 48: Sanofi: Key highlights
Exhibit 49: Sanofi: Strength assessment
Exhibit 50: Sanofi: strategy assessment
Exhibit 51: Sanofi: opportunity assessment



【掲載企業】

Allergan, GlaxoSmithKline, Pfizer, and Sanofi.

Other Prominent Vendors in the market are: Abbott, Ajanta Pharma, Almirall, Astellas Pharma, Bristol-Myers Squibb, CARA Therapeutic, Cipla, Eisai, Eli Lilly, Galderma, Glenmark, Heron Therapeutic, IPCA, Lupin, Merck, Novartis, Sun Pharma, and Takeda Pharmaceutical.


【資料のキーワード】

掻痒症、掻痒症治療薬

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[掻痒症治療薬の世界市場2017-2021]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆